KBPH — Kyto Technology and Life Science Income Statement
0.000.00%
Last trade - 00:00FinancialsHighly SpeculativeMicro Cap
Annual income statement for Kyto Technology and Life Science, fiscal year end - March 31st, USD millions except per share, conversion factor applied.
2017 March 31st | 2018 March 31st | 2019 March 31st | 2020 March 31st | 2021 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 0 | 0 | 0.009 | 0.014 | 0 |
| Selling / General / Administrative Expenses | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 0.094 | 0.091 | 0.239 | 0.788 | 0.769 |
| Operating Profit | -0.094 | -0.091 | -0.23 | -0.773 | -0.769 |
| Total Net Non Operating Interest Income / Expense | |||||
| Net Income Before Taxes | -0.094 | -0.091 | -0.23 | -0.773 | 0.427 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -0.094 | -0.091 | -0.23 | -0.773 | 0.427 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -0.094 | -0.091 | -0.23 | -0.773 | 0.427 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -0.094 | -0.091 | -0.23 | -0.773 | 0.427 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.03 | -0.029 | -0.048 | -0.122 | 0.02 |